MediBeacon

About:

MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care.

Website: http://www.medibeacon.com

Twitter/X: medibeacon

Top Investors: BioGenerator, Missouri Technology Corporation, Jump Capital, Helix Fund, Innovate

Description:

MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care. Its mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological diseases in the human population. Several product concepts in these areas are contained in the MediBeacon Intellectual Property (IP) portfolio. The product pipeline includes real-time kidney function monitoring, a huge leap forward in the world of nephrology. The clinical history and road to FDA and European approvals on this component of the MediBeacon pipeline as well as other developments related to the platform of fluorescent agents and their potential clinical application.

Total Funding Amount:

$91.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

St Louis, Missouri, United States

Founded Date:

2011-01-01

Contact Email:

Hanley(AT)medibeacon.com

Founders:

Richard Dorshow, Steve Hanley

Number of Employees:

11-50

Last Funding Date:

2022-07-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai